Matching Adjusted Indirect Comparison (MAIC) of 177 Lu-DOTATATE Vs. Sunitinib As First-Line (1L) Treatment for Advanced Grade 2 (G2) Pancreatic Neuroendocrine Tumors (Pnets).
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined